A. B. Kay

Active 1970–2014

Also published as
A B Kay · A.B. Kay · A. B. KAY
171
Papers
41,244
Citations
119
h-index
171
i10-index

Citations

Citations per year for A. B. Kay1972: 11 citations1973: 9 citations1974: 17 citations1975: 10 citations1976: 7 citations1977: 18 citations1978: 11 citations1979: 24 citations1980: 23 citations1981: 15 citations1982: 24 citations1983: 26 citations1984: 53 citations1985: 65 citations1986: 47 citations1987: 46 citations1988: 52 citations1989: 64 citations1990: 97 citations1991: 155 citations1992: 250 citations1993: 328 citations1994: 348 citations1995: 341 citations1996: 369 citations1997: 418 citations1998: 490 citations1999: 657 citations2000: 530 citations2001: 457 citations2002: 340 citations2003: 429 citations2004: 358 citations2005: 354 citations2006: 333 citations2007: 290 citations2008: 276 citations2009: 298 citations2010: 272 citations2011: 234 citations2012: 236 citations2013: 164 citations2014: 174 citations2015: 169 citations2016: 128 citations2017: 142 citations2018: 109 citations2019: 341 citations2020: 325 citations2021: 285 citations2022: 222 citations2023: 146 citations2024: 199 citations2025: 93 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,479 citing papers, 27.9% of this breakdownUnited Kingdom: 1,082 citing papers, 12.2% of this breakdownCanada: 492 citing papers, 5.5% of this breakdownGermany: 451 citing papers, 5.1% of this breakdownJapan: 398 citing papers, 4.5% of this breakdownItaly: 391 citing papers, 4.4% of this breakdownAustralia: 333 citing papers, 3.7% of this breakdownChina: 317 citing papers, 3.6% of this breakdownFrance: 309 citing papers, 3.5% of this breakdownNetherlands: 242 citing papers, 2.7% of this breakdownBelgium: 229 citing papers, 2.6% of this breakdownSweden: 224 citing papers, 2.5% of this breakdown
0%27.9%Other 21.8%

Fields

  • Medicine76.4%
  • Immunology and Microbiology13.9%
  • Biochemistry, Genetics and Molecular Biology5.3%
  • Neuroscience1.1%
  • Environmental Science0.9%
  • Agricultural and Biological Sciences0.6%
  • Other1.8%

Topics

  • Asthma and respiratory diseases20.5%
  • Allergic Rhinitis and Sensitization7.8%
  • IL-33, ST2, and ILC Pathways5.3%
  • Respiratory and Cough-Related Research3.6%
  • Eosinophilic Esophagitis3.2%
  • Immune Cell Function and Interaction3.2%
  • Other56.4%

Coauthors

All papers

Open in search
  1. Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous (‘idiopathic’) urticaria

    Authors: , , , - British Journal of Dermatology 2014 cited by 170

  2. Eosinophils: Biological Properties and Role in Health and Disease

    Authors: , , , , , , , - Clinical & Experimental Allergy 2008 cited by 825

  3. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics

    Authors: , , , , , , , , - Journal of Clinical Investigation 2003 cited by 842

  4. Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic Asthma

    Authors: , , , , , , , , - New England Journal of Medicine 1992 cited by 2,766

  5. Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low‐level persistence in uninvolved skin

    Authors: , , , , , , - British Journal of Dermatology 2014 cited by 123

  6. Allergy and Allergic Diseases

    Authors: - New England Journal of Medicine 2001 cited by 1,371

  7. Eosinophil's Role Remains Uncertain as Anti–Interleukin-5 only Partially Depletes Numbers in Asthmatic Airway

    Authors: , , , - American Journal of Respiratory and Critical Care Medicine 2003 cited by 809

  8. Anti–IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics

    Authors: , , , , , , , - Journal of Allergy and Clinical Immunology 2003 cited by 275

  9. Eotaxin (CCL11) and Eotaxin-2 (CCL24) Induce Recruitment of Eosinophils, Basophils, Neutrophils, and Macrophages As Well As Features of Early- and Late-Phase Allergic Reactions Following Cutaneous Injection in Human Atopic and Nonatopic Volunteers

    Authors: , , , , , , - The Journal of Immunology 2002 cited by 252

  10. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: Comparison with the allergen-induced late-phase cutaneous reaction

    Authors: , , , , - Journal of Allergy and Clinical Immunology 2002 cited by 270

  11. The early history of the eosinophil

    Authors: - Clinical & Experimental Allergy 2014 cited by 107

  12. A role for eosinophils in airway remodelling in asthma

    Authors: , , - Trends in Immunology 2004 cited by 336

  13. Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis

    Authors: , , , , , , , - Thorax 1998 cited by 168

  14. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co‐localization of eotaxin mRNA to bronchial epithelial and endothelial cells

    Authors: , , , , , , , , , , , - European Journal of Immunology 1997 cited by 425

  15. Local expression of ϵ germline gene transcripts and RNA for the ϵ heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthma

    Authors: , , , , , , , - Journal of Allergy and Clinical Immunology 2001 cited by 176

  16. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-γ

    Authors: , , , , , , , - Journal of Allergy and Clinical Immunology 1996 cited by 415

  17. Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial

    Authors: , , - The Lancet 2002 cited by 350

  18. Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin

    Authors: , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2000 cited by 202

  19. Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses

    Authors: , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2011 cited by 188

  20. The role of T lymphocytes in the pathogenesis of asthma

    Authors: , , - Journal of Allergy and Clinical Immunology 2003 cited by 572

  21. Eosinophil Chemotactic Chemokines (Eotaxin, Eotaxin-2, RANTES, Monocyte Chemoattractant Protein-3 (MCP-3), and MCP-4), and C-C Chemokine Receptor 3 Expression in Bronchial Biopsies from Atopic and Nonatopic (Intrinsic) Asthmatics

    Authors: , , , , , , - The Journal of Immunology 1999 cited by 415

  22. Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma

    Authors: , , , , , , , , - Journal of Allergy and Clinical Immunology 1992 cited by 226

  23. Peptide immunotherapy in allergic asthma generates IL-10–dependent immunological tolerance associated with linked epitope suppression

    Authors: , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2009 cited by 208

  24. Allergen-Derived T Cell Peptide-Induced Late Asthmatic Reactions Precede the Induction of Antigen-Specific Hyporesponsiveness in Atopic Allergic Asthmatic Subjects

    Authors: , , - The Journal of Immunology 2001 cited by 170